Boston, MA 05/29/2013 (wallstreetpr) – In Tuesday’s trading session, shares of MAKO Surgical Corp (NASDAQ:MAKO) rose by 9.36%. The opening price $12.24 touched an intraday high of $12.73 before dipping to $12.04 per share. Over 2.58M shares were traded in Tuesday’s trading session which was strikingly higher than the average volume of 0.969M that was measured over a period of 30 days
Leading analysts have upgraded MAKO’s stock to an “outperform” rating. In addition to this, on 7 May, the company announced its operating results for the quarter that ended 31 March 2013. The company’s revenue was $24.8 million in the 2013 first quarter, in comparison to $19.6 million that it stood at, in the 2012 first quarter. This represented an increase of 26 percent. Net loss for the quarter that ended 31 March 2013 was $9.6 million, or amounted to $ 0.21 per basic and diluted share. This was based 46.8 million shares outstanding.
MAKO Surgical Corp (NASDAQ:MAKO) is a medical device company. The company markets its advanced, robotic-arm solution. It also has joint specific applications that are used for the hip and knee replacements as well as orthopedic implants that are used in various orthopedic procedures. MAKO Surgical Corp (NASDAQ:MAKO) offers a restorative surgical solution, MAKOplasty. This solution enables orthopedic surgeons to treat osteoarthritic disease that is patient specific. This is performed with the use of MAKO Surgical Corp (NASDAQ:MAKO)’s Robotic Arm Interactive Orthopedic system. The technology platform utilizes a tactile guided robotic arm technology. It also has patient specific planning as well as visualization. This functionality offers surgeons with reproducible precision while conducting the surgery.
